GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Mesalazine Pellets 0.5g
B. Mesalazine Pellets 1g
C. Mesalazine Pellets 2g

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Mesalazine Pellets 0.5g
Each sachet contains:
Mesalazine IP …………… 0.5g
(As pellets)
Excipients……………………………. q.s

B. Mesalazine Pellets 1g
Each sachet contains:
Mesalazine IP …………… 1g
(As pellets)
Excipients……………………………. q.s


C. Mesalazine Pellets 2g Each sachet contains:
Mesalazine IP …………… 2g
(As pellets)
Excipients……………………………. q.s

THERAPEUTIC INDICATIONS:

Mesalazine is indicated for the induction of remission in patients with active or mild to moderate acute exacerbations of ulcerative colitis and for the maintenance of remission of ulcerative colitis.

CAUTION & SCHEDULE:

CAUTION: Oral for inflammatory bowel diseases.
Read enclosed leaflet before use.
SCHEDULE: SCHEDULE H Drug- Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
KEEP MEDICINE OUT OF REACH OF CHILDREN.

STORAGE & DOSAGE:

Storage: Store in a cool & dry place.
Protect from light & moisture.
Preserve in a tight container.
Dosage: As directed by physician.

Mesalazine Pellets 1g Technical Specification:

Product Name:                                     Mesalazine Pellets 1g
Brand Name:Meslataj
Strength:0.5g, 1g, 2g
Dosage Form:Sachet
Route of Administration:Via oral Route
Packing:30 sachet, 120 sachet
Pack Insert/Leaflet:PIL (Patient Information Leaflet)
Regulatory Documents:COA, MOA, Stability Studies, GMP
Therapeutic use:Anti-inflammatory
Indication: Mesalazine is indicated for the induction of remission in patients with active or mild to moderate acute exacerbations of ulcerative colitis and for the maintenance of remission of ulcerative colitis.
Storage:Store in a cool & dry place. Protect from light & moisture. Preserve in a tight container.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Mesalazine Pellets 1g

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Mesalazine Pellets 1g
    Each sachet contains:
    Mesalazine IP …………… 1g
    (As pellets)
    Excipients……………………………. q.s

THERAPEUTIC INDICATIONS:

Mesalazine is indicated for the induction of remission in patients with active or mild to moderate acute exacerbations of ulcerative colitis and for the maintenance of remission of ulcerative colitis.

CAUTION & schedule:

CAUTION:  Oral for inflammatory bowel diseases.

Read enclosed leaflet before use.

schedule: schedule H Drug- Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.

Keep medicine out of reach of children.

STORAGE & DOSAGE:

Storage:  Store in a cool & dry place. Protect from light & moisture. Preserve in a tight container.

Dosage:  As directed by physician.